Heron Therapeutics, Inc. (HRTX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 2.0650 |
| Open | 2.2000 |
| Bid | 1.9100 x 3200 |
| Ask | 1.9300 x 4000 |
| Day's range | 1.8000 - 2.2000 |
| 52-week range | 1.8000 - 6.3800 |
| Volume | |
| Avg. volume | 1,761,832 |
| Market cap | 226.482M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Heron Therapeutics (HRTX) Reports Q4 Loss, Tops Revenue Estimates
Heron Therapeutics (HRTX) delivered earnings and revenue surprises of 32% and 13.53%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
The past three years for Heron Therapeutics (NASDAQ:HRTX) investors has not been profitable
Heron Therapeutics, Inc. ( NASDAQ:HRTX ) shareholders should be happy to see the share price up 12% in the last month...
© 2023 Yahoo. All rights reserved.
